Niraparib
Drug timelines are a Plus or Pro feature.
113 regulatory and trial events tracked for Niraparib, covering 2013-07-25 to 2026-06-03. Get the full timeline:
Most recent: Clinical Trial Results: Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation [Phase 2]